Cubist Systematic Strategies’s Corvus Pharmaceuticals CRVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,026
| Closed | -$52.9K | – | 1646 |
|
|
2024
Q3 | $52.9K | Sell |
10,026
-14,338
| -59% | -$75.7K | ﹤0.01% | 1277 |
|
|
2024
Q2 | $44.3K | Buy |
+24,364
| New | +$44.3K | ﹤0.01% | 1241 |
|
|
2023
Q3 | – | Sell |
-15,552
| Closed | -$35.6K | – | 2093 |
|
|
2023
Q2 | $35.6K | Buy |
+15,552
| New | +$35.6K | ﹤0.01% | 1944 |
|
|
2022
Q2 | – | Sell |
-6,600
| Closed | -$11K | – | 3845 |
|
|
2022
Q1 | $11K | Sell |
6,600
-16,645
| -72% | -$27.7K | ﹤0.01% | 3469 |
|
|
2021
Q4 | $56K | Buy |
23,245
+3,193
| +16% | +$7.69K | ﹤0.01% | 3295 |
|
|
2021
Q3 | $97K | Buy |
+20,052
| New | +$97K | ﹤0.01% | 2748 |
|
|
2017
Q4 | – | Sell |
-1,914
| Closed | -$31K | – | 1937 |
|
|
2017
Q3 | $31K | Buy |
+1,914
| New | +$31K | ﹤0.01% | 1756 |
|
|
2017
Q2 | – | Sell |
-1,429
| Closed | -$30K | – | 1707 |
|
|
2017
Q1 | $30K | Buy |
1,429
+901
| +171% | +$18.9K | ﹤0.01% | 1523 |
|
|
2016
Q4 | $8K | Buy |
+528
| New | +$8K | ﹤0.01% | 1660 |
|